Against the background of an increasingly aging global population, the incidence of thrombotic and hemostatic diseases, including cardiovascular diseases, remains high.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Swedish diagnostics firm Devyser said Thursday that its next-generation sequencing-based test for stem cell transplantation monitoring has received regulatory approval in Canada.

Agilent Technologies Inc. (NYSE: A) held a ribbon-cutting ceremony at the Shanghai Waigaoqiao New Development Park to celebrate the 30th anniversary of the Agilent Shanghai Manufacturing Center (ATS) and announce the official opening of its new Chromatography Column Manufacturing Center.

Scout Health announced Wednesday that it has been awarded up to $6 million in funding support from the antimicrobial resistance nonprofit CARB-X. The firm plans to use the funding to finalize development of a next-generation version of its rapid point-of-care system and assay for chlamydia and gonorrhea and hopes to soon begin pilot studies in low- and middle-income countries (LMICs).

As part of its strategic expansion into precision dermatology, Castle Biosciences recently introduced a new assay to guide systemic treatment decision making for the immune-driven disease atopic dermatitis. Castle expects to expand the limited launch of its AdvanceAD-Tx test over the next year to pursue a total addressable market that it estimates to be as much as $33 billion.

On December 2, 2025, Merck announced that Rogier Janssens will officially assume the role of President of Merck China starting February 1, 2026.

Diagnostics firm IdentifySensors Biologics has recently demonstrated proof of concept for the use of its electrochemical sensor-based diagnostic platform Check4 for cancer testing and is now moving closer to commercialization of the platform and related tests.

New research suggests that individuals who consistently carry Staphylococcus aureusin their noses have other nasal microbial community features that are distinct from those found in individuals without persistent S. aureus colonization.

JP Morgan, BTIG, and Jefferies announced separately Monday that they have initiated coverage of molecular diagnostics firm BillionToOne.

Circular Genomics announced Monday that it raised $15 million in a Series A financing round led by Mountain Group Partners.

In honour of World AIDS Day 2025, AIDS Healthcare Foundation (AHF) UK will host two community events to emphasize that the work to end HIV/AIDS is not over.